Open AccessTime to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
Author(s) -
Yuka Endo,
Akiyo Yoshimura,
Masataka Sawaki,
Masaya Hattori,
Haruru Kotani,
Ayumi Kataoka,
Nanae Horisawa,
Yuri Ozaki,
Kazuki Nozawa,
Daiki Takatsuka,
Ayaka Isogai,
Hiroji Iwata
Publication year - 2022
Publication title -
journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 36
eISSN - 2092-9900
pISSN - 1738-6756
DOI - 10.4048/jbc.2022.25.e34
Subject(s) - medicine , cyclin dependent kinase 4 , fulvestrant , breast cancer , palbociclib , oncology , estrogen receptor , cancer , chemotherapy , metastatic breast cancer , cell cycle , cyclin dependent kinase 2
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom